Icon

ICOTYDE - (EQ 200MG BASE; TABLET)

ICOTROKINRA HYDROCHLORIDE None
EQ 200MG BASE; TABLET
Less Than $1000 mn
None None
None None
None None
ICOTYDE is an interleukin-23 (IL-23) receptor antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy.
Yes
ICOTYDE Patent 1 Patent 2 Patent 3
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.